FAPESP funds $680 million to support 17 RIDCs

The Brazilian funding agency for scientific and technological research S-o Paulo Research Foundation, FAPESP, based in the state of S-o Paulo, announced an investment estimated in US$ 680 million to support 17 Research, Innovation and Dissemination Centers (RIDCs) for a period of up to eleven years, subject to continuation reviews on years 2, 4 and 7.

Funding for the 17 RIDCs will come from FAPESP and the host institutions (through funding faculty, technicians, support personnel, and infrastructure). Host institutions will participate in a portion of US$ 310 million of this amount for the payment of salaries and additional funding will be obtained by each center from industry and government organizations.

Each selected RIDC is expected to establish a hub of excellent research in its focus area. In addition, each RIDC must actively seek out and develop opportunities to have its research results contribute to commercially and/or socially relevant high-impact applications, as well as contributing to education and dissemination of knowledge.

The 17 RIDCs bring together 535 scientists from the State of S-o Paulo and 69 scientists from other countries. The research topics covered by the centers include the following: food and nutrition; glasses and glass-ceramics; functional materials; neuroscience and neurotechnology; inflammatory diseases; biodiversity and drug discovery; toxins, immune-response and cell signaling; neuromathematics; mathematical sciences applied to industry; obesity and associated diseases; cellular therapy; metropolitan studies; human genome and stem-cells; computational engineering; redox processes in biomedicine; violence; and optics, photonics, and atomic and molecular physics.

THE 17 RESEARCH, INNOVATION AND DISSEMINATION CENTERS (RIDCs)

  • Food Research Center - FoRC
  • Center for Research, Teaching, and Innovation in Glass - CEPIV
  • Center for Research and Development of Functional Materials - CDFM
  • Brazilian Research Institute for Neuroscience and Neurotechnology - BRAINN
  • Center for Research on Inflammatory Diseases - CRID
  • Center for Research and Innovation in Biodiversity and Drug Discovery - CIBFar
  • Center for Research on Toxins, Immune Response and Cell Signaling - CeTICS
  • Research, Innovation and Dissemination Center for Neuromathematics - NEUROMAT
  • Center for Research in Mathematical Sciences Applied to Industry - CeMEAI
  • Obesity and Co-Morbidities Research Center - OCRC
  • Center for Research in Cell Therapy - CTC
  • Center for Metropolitan Studies - CEM
  • Human Genome and Stem-Cell Research Center - HUG-CELL
  • Center for Computational Science and Engineering - CECC
  • Center for Research on Redox Processes in Biomedicine - REDOXOME
  • Center for the Study of Violence - NEV-USP
  • Optics and Photonics Research Center - CEPOF

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity